Article

Low Expression of Keratin17 is Related to Poor Prognosis in Bladder Cancer

OncoTargets and Therapy · 2021 · Wu J, Xu H, Ji H, Zhai B, Zhu J, Gao M, Zhu H, Wang X

Key facts

Title Low Expression of Keratin17 is Related to Poor Prognosis in Bladder Cancer
First author Wu J, Xu H, Ji H, Zhai B, Zhu J, Gao M, Zhu H, Wang X
Journal OncoTargets and Therapy
Published Jan 19, 2021
DOI 10.2147/OTT.S287891
Devices mentioned K103302, K852441, K854177, K854178, K854179, K854180, K854181, K854182, K854183, K854184, K854185, K854186 and 2 more
Product codes mentioned CDT, CEO, CGA, CGX, CHH, CIG, CIS, CIX, CJE, CKA, KLB, KLS and 5 more

At a glance

  • 10–99 FDA submissions mentioned
  • 10–99 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature